BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 10582666)

  • 1. The p27/Kip1 locus shows no loss of heterozygosity in human pituitary adenomas.
    Wilson JC; Zhu JJ; Black PM
    J Neurooncol; 1999 Aug; 44(1):35-9. PubMed ID: 10582666
    [No Abstract]   [Full Text] [Related]  

  • 2. Infrequent mutations of p27Kip1 gene and trisomy 12 in a subset of human pituitary adenomas.
    Tanaka C; Yoshimoto K; Yang P; Kimura T; Yamada S; Moritani M; Sano T; Itakura M
    J Clin Endocrinol Metab; 1997 Sep; 82(9):3141-7. PubMed ID: 9284759
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutation and expression analysis of the cyclin-dependent kinase inhibitor gene p27/Kip1 in pituitary tumors.
    Takeuchi S; Koeffler HP; Hinton DR; Miyoshi I; Melmed S; Shimon I
    J Endocrinol; 1998 May; 157(2):337-41. PubMed ID: 9659297
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular analysis of p21 and p27 genes in human pituitary adenomas.
    Ikeda H; Yoshimoto T; Shida N
    Br J Cancer; 1997; 76(9):1119-23. PubMed ID: 9365157
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutation and expression analysis of the p27/kip1 gene in corticotrophin-secreting tumours.
    Dahia PL; Aguiar RC; Honegger J; Fahlbush R; Jordan S; Lowe DG; Lu X; Clayton RN; Besser GM; Grossman AB
    Oncogene; 1998 Jan; 16(1):69-76. PubMed ID: 9467944
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduced expression levels of the cell-cycle inhibitor p27Kip1 in human pituitary adenomas.
    Bamberger CM; Fehn M; Bamberger AM; Lüdecke DK; Beil FU; Saeger W; Schulte HM
    Eur J Endocrinol; 1999 Mar; 140(3):250-5. PubMed ID: 10216521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. p27Kip1-deficient mice exhibit accelerated growth hormone-releasing hormone (GHRH)-induced somatotrope proliferation and adenoma formation.
    Teixeira LT; Kiyokawa H; Peng XD; Christov KT; Frohman LA; Kineman RD
    Oncogene; 2000 Apr; 19(15):1875-84. PubMed ID: 10773877
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CDK inhibitors p18(INK4c) and p27(Kip1) mediate two separate pathways to collaboratively suppress pituitary tumorigenesis.
    Franklin DS; Godfrey VL; Lee H; Kovalev GI; Schoonhoven R; Chen-Kiang S; Su L; Xiong Y
    Genes Dev; 1998 Sep; 12(18):2899-911. PubMed ID: 9744866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frequent loss of the CDKN2C (p18INK4c) gene product in pituitary adenomas.
    Kirsch M; Mörz M; Pinzer T; Schackert HK; Schackert G
    Genes Chromosomes Cancer; 2009 Feb; 48(2):143-54. PubMed ID: 18973139
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor suppressor loss in pituitary tumors.
    Alexander JM
    Brain Pathol; 2001 Jul; 11(3):342-55. PubMed ID: 11414476
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low expression of the cell cycle inhibitor p27Kip1 in normal corticotroph cells, corticotroph tumors, and malignant pituitary tumors.
    Lidhar K; Korbonits M; Jordan S; Khalimova Z; Kaltsas G; Lu X; Clayton RN; Jenkins PJ; Monson JP; Besser GM; Lowe DG; Grossman AB
    J Clin Endocrinol Metab; 1999 Oct; 84(10):3823-30. PubMed ID: 10523037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mice lacking p27(Kip1) display increased body size, multiple organ hyperplasia, retinal dysplasia, and pituitary tumors.
    Nakayama K; Ishida N; Shirane M; Inomata A; Inoue T; Shishido N; Horii I; Loh DY; Nakayama K
    Cell; 1996 May; 85(5):707-20. PubMed ID: 8646779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical significance of molecular genetic changes in sporadic invasive pituitary adenomas.
    Nam DH; Song SY; Park K; Kim MH; Suh YL; Lee JI; Kim JS; Hong SC; Shin HJ; Park K; Eoh W; Kim JH
    Exp Mol Med; 2001 Sep; 33(3):111-6. PubMed ID: 11642545
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A syndrome of multiorgan hyperplasia with features of gigantism, tumorigenesis, and female sterility in p27(Kip1)-deficient mice.
    Fero ML; Rivkin M; Tasch M; Porter P; Carow CE; Firpo E; Polyak K; Tsai LH; Broudy V; Perlmutter RM; Kaushansky K; Roberts JM
    Cell; 1996 May; 85(5):733-44. PubMed ID: 8646781
    [TBL] [Abstract][Full Text] [Related]  

  • 15. p27 and Rb are on overlapping pathways suppressing tumorigenesis in mice.
    Park MS; Rosai J; Nguyen HT; Capodieci P; Cordon-Cardo C; Koff A
    Proc Natl Acad Sci U S A; 1999 May; 96(11):6382-7. PubMed ID: 10339596
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of loss of heterozygosity on chromosome 11 and infrequent inactivation of the MEN1 gene in sporadic pituitary adenomas.
    Tanaka C; Kimura T; Yang P; Moritani M; Yamaoka T; Yamada S; Sano T; Yoshimoto K; Itakura M
    J Clin Endocrinol Metab; 1998 Aug; 83(8):2631-4. PubMed ID: 9709923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transforming growth factor-beta, transforming growth factor-beta receptor II, and p27Kip1 expression in nontumorous and neoplastic human pituitaries.
    Jin L; Qian X; Kulig E; Sanno N; Scheithauer BW; Kovacs K; Young WF; Lloyd RV
    Am J Pathol; 1997 Aug; 151(2):509-19. PubMed ID: 9250163
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p27 Expression, a cyclin dependent kinase inhibitor in breast carcinoma.
    Barbareschi M
    Adv Clin Path; 1999 Oct; 3(4):119-27. PubMed ID: 10936889
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p27/Kip1 mutation found in breast cancer.
    Spirin KS; Simpson JF; Takeuchi S; Kawamata N; Miller CW; Koeffler HP
    Cancer Res; 1996 May; 56(10):2400-4. PubMed ID: 8625318
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The concurrent expression of p27(kip1) and cyclin D1 in epithelial ovarian tumors.
    Sui L; Tokuda M; Ohno M; Hatase O; Hando T
    Gynecol Oncol; 1999 May; 73(2):202-9. PubMed ID: 10329035
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.